PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30081056-8	2018	Bupropion showed a clear anti-oxidant/anti-inflammatory profile detected by the ELISA assay of malondialdehyde (MDA), reduced glutathione, and interleukin -6 (IL-6), and real-time gene expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and tumor necrosis factor-alpha (TNF-alpha).	Bupropion	0-9	tumor necrosis factor	Rattus norvegicus	254-281	
32594336-8	2020	Regarding biochemical factors, following colitis induction, TNF-alpha level and MPO activity were increased; nevertheless, dexamethasone (2 mg/kg) and bupropion (160 mg/kg) decreased the TNF-alpha and MPO activity.	Bupropion	151-160	tumor necrosis factor	Rattus norvegicus	60-69	
32594336-8	2020	Regarding biochemical factors, following colitis induction, TNF-alpha level and MPO activity were increased; nevertheless, dexamethasone (2 mg/kg) and bupropion (160 mg/kg) decreased the TNF-alpha and MPO activity.	Bupropion	151-160	tumor necrosis factor	Rattus norvegicus	187-196	
30081056-8	2018	Bupropion showed a clear anti-oxidant/anti-inflammatory profile detected by the ELISA assay of malondialdehyde (MDA), reduced glutathione, and interleukin -6 (IL-6), and real-time gene expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and tumor necrosis factor-alpha (TNF-alpha).	Bupropion	0-9	tumor necrosis factor	Rattus norvegicus	283-292	
23953570-2	2013	Bupropion is an antidepressant known to inhibit TNF-alpha production.	Bupropion	0-9	tumor necrosis factor	Rattus norvegicus	48-57	
23953570-9	2013	Bupropion in reduced intestinal I/R injury through immunomodulatory machanisms that involve inflammatory cytokines such as TNF-alpha.	Bupropion	0-9	tumor necrosis factor	Rattus norvegicus	123-132